COVID vaccination EOIs give general practices ‘a seat at the table’ The RACGP is encouraging practices to submit their expression of interest, along with any concerns around the proposed delivery and funding model.
Will the new COVID vaccine ads help curb hesitancy? The $24 million campaign is aimed at reassuring Australians that the vaccines used in the rollout are safe and effective.
Opinion versus evidence: Searching for vaccine certainty Dr Natasha Yates examines the issue of navigating data, misinformation and vaccine hesitancy among patients and healthcare workers.
Pfizer COVID vaccine first to be approved in Australia The TGA has granted provisional approval ahead of next month’s planned rollout, which will now start in late February due to production delays.
Government seeks general practice EOIs for COVID vaccine rollout GPs will form the backbone of ‘one of the greatest logistical exercises’ in Australian history.
It’s crucial COVID vaccine hesitancy among health workers is addressed Deputy Chair for the Collaboration on Social Science and Immunisation Associate Professor Holly Seale reveals where to start.
COVID vaccine restrictions possible following elderly deaths in Norway But experts have called for calm, as the connection between the Pfizer/BioNtech vaccine and mortality in frail older people remains unclear.
Efficacy rate alone not enough to determine overall value of a vaccine Many have highlighted AstraZeneca’s apparent 62% efficacy as a reason for Australia to seek out alternatives, but the candidate has a number of other significant advantages.
How important are COVID vaccine efficacy rates? Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
Vaccines that do not prevent or cure COVID still beneficial: Study As Australia moves closer to its COVID vaccine rollout, experts discuss new US modelling that suggests reducing the virus’ contagious period could prevent millions of cases.